razoxane has been researched along with Genetic Non-Disjunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amor-Guéret, M; Buhagiar-Labarchède, G; Fontaine, G; Gemble, S; Lambert, S; Onclercq-Delic, R | 1 |
| Eastmond, DA; Roy, SK | 1 |
2 other study(ies) available for razoxane and Genetic Non-Disjunction
| Article | Year |
|---|---|
Topoisomerase IIα prevents ultrafine anaphase bridges by two mechanisms.
Topics: Anaphase; Chromosome Segregation; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; HeLa Cells; Humans; Nondisjunction, Genetic; Poly-ADP-Ribose Binding Proteins; Razoxane | 2020 |
Bimolane induces multiple types of chromosomal aberrations in human lymphocytes in vitro.
Topics: Antineoplastic Agents; Cells, Cultured; Chromosome Aberrations; Humans; In Situ Hybridization, Fluorescence; Leukemia; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Mutagens; Neoplasms, Second Primary; Nondisjunction, Genetic; Polyploidy; Razoxane | 2011 |